Coagulation/Hemostasis AnalyzerLab-based and point-of-care (POC) coagulation/hematology testing is performed to determine if a person has a level of coagulation activity that is sufficient to control the blood clotting process. Over the past decade, the global hemostasis market has witnessed challenging and dynamic market conditions due to factors such as high competition amongst market players, adoption of technologically advanced coagulation analyzers, other instruments and reagents, and increasing healthcare awareness among the population globally.

A new report from Markets and Markets predicts that the global coagulation analyzers market will reach a value of $3.58 billion by 2019 from $2.4 billion in 2014, growing at a CAGR of 8.3% from 2014 to 2019.

The report segments the market in terms of the type of product, test type, technology, end user and geography, and states that the growth of the market is motivated by the following factors

  • Availability of technologically advanced hemostasis analyzers
  • Increasing adoption of automation platforms
  • Development of high-throughput screening techniques
  • Increasing number of general surgeries and organ transplantations

The key players in the market include Sysmex Corporation (Japan), Siemens Healthcare (Germany), Roche Diagnostics (Switzerland), Helena Laboratories (U.S.), Alere, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.). While North America dominated the global coagulation analyzers market in 2014, the Asia-Pacific region is expected to witness the highest growth in the forecast period.

Common coagulation tests performed in clinical laboratories and point of care include activated partial thromboplastin time (APTT), fibrinogen (Fbg), prothrombin time (PT), international normalized ratio (INR, transformed by PT), and thrombin time (TT) measurements. Timely and accurate coagulation testing and factor detection in fresh plasma samples are critical when it comes to diagnosing and treating hemophilia and to monitor oral anticoagulant therapy, chronic liver disease, and thrombotic disease. To help clinical labs achieve these goals, reputable suppliers of laboratory equipment offer new and recertified coagulation analyzers, coagulation reagents, controls, and consumables at competitive rates.